Sagtec gets Nasdaq notice for minimum bid price deficiency after shares trade below $1
SAGT•Cure requirements and possible next steps
Compliance requires a closing bid price of at least $1 for 10 consecutive business days.
Failure to cure by Feb. 16, 2027 could open a second 180-day period, subject to additional listing standards.
A reverse stock split is under consideration as a potential remedy if needed.
Nasdaq notice for minimum bid price deficiency
Sagtec Global received a Nasdaq notice flagging noncompliance with the $1 minimum bid-price rule after 30 consecutive business days below $1.
Trading on Nasdaq continues during a 180-day cure window that runs to Feb. 16, 2027.
